Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With Metastatic Renal Cell Carcinoma in Latin America

NCT04115189 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04115189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04115189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With Metastatic Renal Cell Carcinoma in Latin America
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
December 13, 2019
Completion date
December 2, 2020
Enrollment
57 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell carcinoma ( mrcc)